Abiopharma

🔍 MOORHEAD DANIEL J (Executive)

Company: Beyond Air, Inc. (XAIR)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 70,000 shares of Stock Option (right to buy) at $0.79 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2036-01-04 | equity_swap_involved: 0 | shares_owned_after: 70,000.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

Footnotes:

• F1: On January 5, 2026, the Issuer issued an inducement grant to the Reporting Person of stock options (the "Options") to buy 70,000 shares of common stock, at a per share exercise price of $0.79, which is equal to the closing price of the Issuer's common stock on January 2, 2026.
• F2: 25% of the options will vest upon the one (1) year anniversary of 01/05/2026, and the remaining will vest annually thereafter in 3 equal installments, provided that, no portion of the stock option that is not exercisable at the time of the reporting person's termination of employment for any reason shall thereafter become exercisable.